Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus

Technol Cancer Res Treat. 2022 Jan-Dec:21:15330338221118211. doi: 10.1177/15330338221118211.

Abstract

Enhanced Recovery After Surgery (ERAS) is the integration of multiple perioperative evidence-based medical practices into a single pathway aimed at eliminating surgical liabilities and improving treatment accuracy to enhance patients' postoperative outcomes. The ERAS Society has been developing guidelines that are widely applicable in the surgical field. ERAS pathways in selective and noncomplicated cases are extensively practiced. However, the ERAS literature excludes patients with comorbidities, such as gastric cancer complicated with diabetes mellitus (DM). Current ERAS guidelines exclude patients with DM in enhanced recovery programs because of insufficient evidence-based medicine on the molecular physiology of the patients in response to surgical insult. Therefore, it is important to implement accelerated rehabilitation surgery for patients with gastric cancer and DM. This review discusses the feasibility and necessity of applying ERAS guidelines to patients with gastric cancer complicated by DM. In addition, we documented the need to lay a logical foundation for enhanced recovery after surgery in patients with gastric cancer complicated by DM.

Keywords: enhanced recovery after surgery; feasibility; gastric cancer complicated with diabetes mellitus; logic foundation; necessity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Enhanced Recovery After Surgery*
  • Feasibility Studies
  • Humans
  • Length of Stay
  • Postoperative Complications / etiology
  • Stomach Neoplasms* / complications
  • Stomach Neoplasms* / surgery